The Hong Kong office of Debevoise & Plimpton has advised Capital Group in its acquisition of an equity stake in Intas Pharmaceuticals Limited (“Intas”), one of…
Capital Group’s $107 Million Investment in Intas Pharmaceuticals
The Hong Kong office of Debevoise & Plimpton has advised Capital Group in its acquisition of an equity stake in Intas Pharmaceuticals Limited (“Intas”), one of…